Pneumonia Diagnostics Market to Reach USD 899.4 Million by 2032 at a 5.6% of CAGR

Discover how advanced pneumonia diagnostics are improving detection accuracy, reducing hospitalizations, and enabling faster treatment.

NEWARK, DE, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- The global pneumonia diagnostics market is set for significant growth, projected to reach a valuation of USD 899.4 million by 2032, expanding at a CAGR of 5.6% from 2022 to 2032. This steady rise is fueled by the increasing prevalence of pneumonia and the urgent need for early and accurate detection to ensure timely treatment. With pneumonia remaining a major global health concern, advancements in diagnostic tools are playing a crucial role in reducing morbidity and mortality rates.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: https://www.futuremarketinsights.com/report-sample#5245502d47422d32393730

Among product segments, streptococcus-based diagnostics emerged as the dominant category in 2021, capturing approximately 36.2% of the global market share. This trend is expected to continue over the forecast period, as healthcare providers increasingly rely on streptococcus-based tests for effective and precise pneumonia diagnosis. The pneumonia diagnostics market accounted for 0.6% of the global in vitro diagnostics market, which was valued at USD 76.3 billion in 2021, highlighting its niche but essential role in the broader diagnostics industry.

Continuous innovations in diagnostic technologies, growing investments in healthcare infrastructure, and government initiatives to combat respiratory diseases are further propelling market growth. The rising adoption of point-of-care testing and molecular diagnostic techniques is revolutionizing pneumonia detection, enabling faster and more accurate results. These advancements are crucial in addressing the growing disease burden, particularly in regions with high pneumonia incidence rates.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

The global pneumonia diagnostics market is expected to reach USD 899.4 million by 2032, growing at a CAGR of 5.6%.
The streptococcus-based diagnostics segment led the market with a 36.2% share in 2021 and is projected to maintain dominance.
Pneumonia diagnostics made up 0.6% of the global in vitro diagnostics market, valued at USD 76.3 billion in 2021.
Technological advancements, increased healthcare investments, and early detection initiatives are key factors driving market expansion.

𝐀 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 - https://www.futuremarketinsights.com/reports/pneumonia-diagnostic-market

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

Key Drivers The rising incidence of pneumonia, increasing focus on early detection of infectious diseases, and advancements in diagnostic techniques are key factors driving the global pneumonia diagnostics market.
Rising Demand An increase in lung infections and infectious diseases has led to a greater demand for pneumonia diagnostics.
Global Health Concern Pneumonia remains a significant worldwide health concern, characterized by high rates of morbidity and mortality. Identifying the microbial pathogens that cause lung infection is crucial for optimal clinical care.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐦𝐚𝐢𝐧 𝐝𝐫𝐢𝐯𝐞𝐫𝐬 𝐛𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭?

The primary drivers behind the growth of the pneumonia diagnostics market are:

Increasing Prevalence of Pneumonia: The rising number of pneumonia cases, influenced by factors such as a growing geriatric population, respiratory infections, and environmental conditions, is a significant driver. Pneumonia remains a leading cause of hospitalization and mortality, increasing the demand for accurate and rapid diagnostic tests for early and effective treatment. For example, UNICEF reported approximately 1 pneumonia case per 71 children, and over 1,400 cases per 100,000 children annually.

Technological Advancements in Diagnostics: Advances in pneumonia testing technologies, including molecular diagnostic tools and rapid point-of-care tests, are propelling market expansion. These innovations allow for quicker and more accurate patient identification, improving patient outcomes and healthcare system efficiency, even in low-resource settings. The development of advanced multiplex PCR (mPCR) platforms, which offer higher detection efficiency while reducing costs and time, is also contributing to market growth.

Growing Focus on Early Detection and Treatment: Increased awareness and concern regarding pneumonia-related mortality are driving the need for early diagnosis and intervention. This is leading to a greater emphasis on preventive care and the adoption of pneumonia diagnostic products1.

Government Initiatives and Healthcare Modernization: Increasing investments and initiatives by governments, especially in emerging countries, to modernize healthcare infrastructure are expected to boost the pneumonia diagnostics market1.

Rising Adoption of Point-of-Care Testing: There's a growing preference for point-of-care diagnostic products due to their convenience, quicker diagnosis, and improved treatment outcomes.

Increased Incidence of Respiratory Infections: A rise in respiratory infections, particularly among the elderly and immunocompromised, is also contributing to the increased demand for pneumonia testing.

𝐈𝐧-𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝟐𝟎+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 - https://www.futuremarketinsights.com/industry-analysis/in-vitro-diagnostics-devices

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

Thermo Fisher Scientific Inc.; Alere Inc.; Quidel Corporation; Becton, Dickinson, and Company; Meridian Bioscience, Inc; Qiagen N.V.; bioMérieux SA; Bio-Rad Laboratories Inc.; Cardinal Health Inc.; Beckman Coulter Inc (DanaherCorporation); Hologic Inc.; La Roche Ltd.; Abbot Laboratories; Quest Diagnostics; Luminex Corporation

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

By Product:

Streptococcus based
Legionella based
Chlamydophilla based
Mycoplasma Pneumonia based
Viral Pneumonia based

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Clinical Diagnostics Industry Outlook from 2025 to 2035 -https://www.futuremarketinsights.com/reports/clinical-diagnostics-market

At-Home Testing Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/at-home-testing-market

Antimicrobial Susceptibility Testing Market Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/antibiotic-susceptibility-testing-market

Pancreatic Stone Protein Testing Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/pancreatic-stone-protein-testing-market

Nephelometry Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/nephelometry-market

Cancer Diagnostics Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/cancer-diagnostics-market

Ovulation Test Kit Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/ovulation-test-kit-market

Dehydrated Culture Media Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/dehydrated-culture-media-market

Advanced At-home Biomarker Testing Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/advanced-at-home-biomarker-testing-market

Automated Nucleic Acid Extraction Systems Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/automated-nucleic-acid-extraction-systems-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ankush Nikam
Future Market Insights, Inc.
+91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Other